Suchergebnisse - "Brufsky, Adam"

PubPharm (533)

101

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

enthalten in: Breast cancer research and treatment | 2021

von Moy, B. | Oliveira, M. | Saura, C. | +22

102

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

enthalten in: Breast cancer research and treatment | 2021

von Moy, B. | Oliveira, M. | Saura, C. | +22

103

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

enthalten in: The New England journal of medicine | 2021

von Bardia, A. | Hurvitz, S. | Tolaney, S. | +117

CommentIn: Nat Rev Clin Oncol. 2021 Jun;18(6):322. - PMID 33931767

104

Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial Resistant Era

enthalten in: Preprints.org | 2021

von Serrano-Aroca, �. | Takayama, K. | Tuñón-Molina, A. | +14

105

Dysregulation of the mevalonate pathway during SARS-CoV-2 infection : An in silico study

enthalten in: Journal of medical virology | 2021

von Gomez Marti, J. | Wells, A. | Brufsky, A.

106

Variability of Accessory Proteins Rules the SARS-CoV-2 Pathogenicity

enthalten in: bioRxiv.org | 2021

von Hassan, S. | Choudhury, P. | Uversky, V. | +21

107

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

enthalten in: Journal of the National Cancer Institute | 2021

von Albain, K. | Gray, R. | Makower, D. | +25

CommentIn: J Natl Cancer Inst. 2021 Apr 6;113(4):349-350. - PMID 32986842

108

Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer

enthalten in: JAMA network open | 2021

von Carleton, N. | Zou, J. | Fang, Y. | +14

109

Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer : A Multicenter Experience

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2021

von Wander, S. | Han, H. | Zangardi, M. | +27

110

Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice

enthalten in: Breast cancer research : BCR | 2021

von DeMichele, A. | Cristofanilli, M. | Brufsky, A. | +8